Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer

  1. Montero, J.C.
  2. Esparís-Ogando, A.
  3. Re-Louhau, M.F.
  4. Seoane, S.
  5. Abad, M.
  6. Calero, R.
  7. Ocaña, A.
  8. Pandiella, A.
Journal:
Oncogene

ISSN: 0950-9232,  1476-5594

Year of publication: 2014

Volume: 33

Issue: 2

Pages: 148-156

Type: Article

DOI: 10.1038/ONC.2012.572 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus